We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 11-20 of 26

Council conclusions

  • Norton Rose LLP
  • -
  • European Union
  • -
  • January 22 2010

On 2 December 2009, the Council of the European Union published conclusions on the Commission Communication entitled Ensuring efficient, safe and sound derivatives markets - Future policy action and on the Commission report entitled The Code of Conduct on clearing and settlement: Three years of experience

House of Lords EU Select Committee call for evidence on Commission Communications on ensuring safe and sound derivatives markets

  • Norton Rose LLP
  • -
  • European Union, United Kingdom
  • -
  • January 22 2010

On 15 December 2009, the House of Lords EU Select Committee issued a call for evidence on the European Commission Communications on ensuring safe and sound derivatives markets

Commission sets out future actions to strengthen the safety of derivatives markets

  • Norton Rose LLP
  • -
  • European Union
  • -
  • October 26 2009

The European Commission has published a press release stating that it has adopted a Communication for ensuring efficient, safe and sound derivatives markets

Some reflections on the future of the market for credit derivatives

  • Norton Rose LLP
  • -
  • European Union
  • -
  • October 12 2009

The European Central Bank (ECB) has published the keynote address given by José Manuel González-Páramo (JMGP) (Member of the Executive Board of the ECB) at the 30th International Burgenstock Meeting on 9 September 2009

Trade repositories in the European Union

  • Norton Rose LLP
  • -
  • European Union
  • -
  • October 12 2009

The Committee of European Securities Regulators (CESR) has published a Consultation Paper, Trade repositories in the European Union

Response to the Commission Consultation Document on the possible initiatives to enhance the resilience of OTC derivatives markets

  • Norton Rose LLP
  • -
  • European Union
  • -
  • October 12 2009

The Committee of European Securities Regulators (CESR) has published its response to the European Commission’s Consultation Document on the possible initiatives to enhance the resilience of OTC derivatives markets

Charlie McCreevy speech - derivatives and risk allocation

  • Norton Rose LLP
  • -
  • European Union
  • -
  • October 12 2009

The European Commission has published a speech given by Charlie McCreevy, European Commissioner for Internal Market and Services, at the Derivatives Conference speakers’ dinner on 24 September 2009

Response to the Commission consultation document on the possible initiatives to enhance the resilience of OTC derivatives markets

  • Norton Rose LLP
  • -
  • European Union
  • -
  • September 24 2009

The Committee of European Securities Regulators (CESR) has published its response to the European Commission’s Consultation Document on the possible initiatives to enhance the resilience of OTC derivatives markets

EU-US Coalition on Financial Regulation - response to CESR call for evidence on mutual recognition of non-EU jurisdictions

  • Norton Rose LLP
  • -
  • European Union, USA
  • -
  • September 24 2009

The EU-US Coalition on Financial Regulation (the Coalition) is an industry-led initiative created in 2005 to push for mutual regulatory recognition between EU member states and the US, as well as targeted rule convergence

IMA response to the European Commission’s consultation on OTC derivatives

  • Norton Rose LLP
  • -
  • European Union, United Kingdom
  • -
  • September 14 2009

The Investment Management Association (IMA) has published a statement welcoming the Commission’s consultation on OTC (over-the-counter) derivatives and agreeing with its objective of making central clearing houses take on most of the responsibility for the clearing and settlement of OTC contracts